http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12014212

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 953
issn 1479-6694
1744-8301
issueIdentifier 8
pageRange 947-953
publicationName Future oncology (London, England)
startingPage 947
bibliographicCitation Gadgeel SM, Bepler G. Crizotinib: an anaplastic lymphoma kinase inhibitor. Future Oncol. 2011 Aug;7(8):947–53. doi: 10.2217/fon.11.77. PMID: 21823889.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_092fc7e1b07ab4864703e168c51299ef
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_082095037526ad53ccac603d70127d47
date 201108
identifier https://doi.org/10.2217/fon.11.77
https://pubmed.ncbi.nlm.nih.gov/21823889
isPartOf https://portal.issn.org/resource/ISSN/1479-6694
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32856
https://portal.issn.org/resource/ISSN/1744-8301
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Crizotinib: an anaplastic lymphoma kinase inhibitor
discusses http://id.nlm.nih.gov/mesh/M0328256
http://id.nlm.nih.gov/mesh/M0228330
http://id.nlm.nih.gov/mesh/M0493054
http://id.nlm.nih.gov/mesh/M0457532
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0018233
http://id.nlm.nih.gov/mesh/M0018226
http://id.nlm.nih.gov/mesh/M0553416
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D011725Q000627
http://id.nlm.nih.gov/mesh/D002289Q000188
http://id.nlm.nih.gov/mesh/D047428Q000627
http://id.nlm.nih.gov/mesh/D020794Q000037
http://id.nlm.nih.gov/mesh/D008175Q000188
http://id.nlm.nih.gov/mesh/D000970Q000627
http://id.nlm.nih.gov/mesh/D011720Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000970Q000493
http://id.nlm.nih.gov/mesh/D011725Q000493
http://id.nlm.nih.gov/mesh/D009154Q000235
http://id.nlm.nih.gov/mesh/D000077548
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D002289Q000201
http://id.nlm.nih.gov/mesh/D000970Q000737
http://id.nlm.nih.gov/mesh/D015321Q000235
http://id.nlm.nih.gov/mesh/D020794Q000235
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D047428Q000737
http://id.nlm.nih.gov/mesh/D011725Q000737
http://id.nlm.nih.gov/mesh/D011720Q000493
http://id.nlm.nih.gov/mesh/D008175Q000201
http://id.nlm.nih.gov/mesh/D011720Q000737
http://id.nlm.nih.gov/mesh/D000077547
http://id.nlm.nih.gov/mesh/D002289Q000235
http://id.nlm.nih.gov/mesh/D008175Q000235
http://id.nlm.nih.gov/mesh/D019008Q000235
http://id.nlm.nih.gov/mesh/D047428Q000493
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6137
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6795
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9603
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c4c4909eaa4fc41a39f0fa5c96f30cd6
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11626560
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243164928
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID376229599
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID160644611

Total number of triples: 69.